HIV protease inhibitors and insulin resistance: Lessons from in-vitro, rodent and healthy human volunteer models

Medicine & Life Sciences

• Adipokines 15%
• Cardiovascular Diseases 9%
• Cytokines 8%
• Diabetes Mellitus 10%
• Facilitative Glucose Transport Proteins 15%
• Glucose 8%
• Healthy Volunteers 45%
• HIV Protease Inhibitors 100%
• Homeostasis 10%
• In Vitro Techniques 30%
• Insulin Resistance 56%
• Oxidative Stress 10%
• Pharmacokinetics 10%
• Protease Inhibitors 42%
• Rodentia 57%
• Therapeutics 2%